Table 2 from Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients
Authors:
- Takami SatoTSTakami Sato
- Marcus O. ButlerMBMarcus O. Butler
- Sophie Piperno-NeumannSPSophie Piperno-Neumann
- Jessica C. HasselJessica C. Hassel
- Paul NathanPNPaul Nathan
- Alexander N. ShoushtariASAlexander N. Shoushtari
- Piotr RutkowskiPRPiotr Rutkowski
- Richard D. CarvajalRichard D. Carvajal
- Jean-Francois BaurainJBJean-Francois Baurain
- Max SchlaakMSMax Schlaak
- Josep M. PiulatsJPJosep M. Piulats
- Ryan J. SullivanRSRyan J. Sullivan
Open Access
- 1 December 2025
- other
- Published by American Association for Cancer Research (AACR)